Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer Secondary Analysis of the GeparSixto Randomized Clinical Trial

Erstveröffentlichung
2017Authors
Hahnen, Eric
Lederer, Bianca
Hauke, Jan
Loibl, Sibylle
Kroeber, Sandra
Wissenschaftlicher Artikel
Published in
JAMA Oncology ; 3 (2017), 10. - S. 1378-1385. - ISSN 2374-2437. - eISSN 2374-2445
Link to publication
https://dx.doi.org/10.1001/jamaoncol.2017.1007Institutions
UKU. Klinik für Frauenheilkunde und GeburtshilfeSubject headings
[Free subject headings]: ovarian-cancer | susceptibility gene | phase-2 trial | chemotherapy | carboplatin | doxorubicin | rates[DDC subject group]: DDC 610 / Medicine & health